DJIA 16,792.76 2.57 0.02%
NASDAQ 4,741.69 -6.67 -0.14%
S&P 500 1,979.87 -0.05 0.00%
market minute promo

ImmunoGen (NASDAQ: IMGN)

11.05 0.36 (3.37%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

IMGN $11.05 3.37%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $10.42
Previous Close $10.69
Daily Range $10.31 - $10.96
52-Week Range $5.34 - $19.43
Market Cap $960.9M
P/E Ratio -15.06
Dividend (Yield) $0.00 (0.0%)
Volume 399,378
Average Daily Volume 1,590,275
Current FY EPS -$1.42




Drug Makers

ImmunoGen (IMGN) Description

ImmunoGen develops cancer therapeutics through its tumor-activated, prodrug technology, which targets antibodies with cancer-killing drugs. Website:

News & Commentary Rss Feed

Why Biotech Took a Beating Today

What goes up must come down.

Benzinga's Top Downgrades

Why ImmunoGen Fell 15% Today

ImmunoGen's shares are falling after its investor conference last week and amid an industry wide rout.

New Biotech Pair Trade: Infinity Pharma Over ImmunoGen

Mid-Morning Market Update: Markets Open Higher; Lennar Tops Q3 Views

Mid-Morning Market Update: Markets Open Higher; Lennar Tops Q3 Views

Immunogen (IMGN) Stock: Weak On High Volume Today

Friday's ETF with Unusual Volume: XBI

Why ImmunoGen Shares Are Falling Today

ImmunoGen investors are giving back yesterday's gains following the company's investor presentation today.

Immunogen (IMGN) In A Perilous Reversal

See More IMGN News...

IMGN's Top Competitors

IMGN $11.05 (3.37%)
Current stock: IMGN
AMGN $146.23 (3.55%)
Current stock: AMGN
GILD $99.83 (2.35%)
Current stock: GILD
BIIB $283.51 (2.72%)
Current stock: BIIB